SEC Form 4 · accession 0001654954-17-003280
TG THERAPEUTICS, INC. · TGTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William James Kennedy
Director
Period of report
Apr 11, 2017
Accepted (ET)
Apr 12, 2017 · 5:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001316
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF2 | Apr 11, 2017 | S | 8,548 | $10.27 | D | 70,401 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale of a total of 8,548 shares was made to satisfy Mr. Kennedy's income tax obligations from the vesting of restricted stock shares in 2016.
- F2Includes shares of restricted Common Stock, which vest over various time periods.